Funding Stability The organization is fully self-funded through grants and donor funds with a revenue range of 25 to 50 million USD, indicating strong financial foundation and potential for multi-year partnerships or sponsored programs in HIV and TB research, treatment, and education.

Public Health Focus Focused on HIV and TB research, treatment, prevention, and education in Southern Africa, offering opportunities to collaborate on Vaccine trials, adolescent health research, school-based prevention initiatives, and open-access educational tools like SOGI Universe.

Academic Partnerships Affiliation with the Desmond Tutu HIV Centre at the University of Cape Town and history of collaboration with SAMRC and IAVI suggest pathways for joint grant proposals, clinical research services, and access to academic networks for co-development and research funding.

Technical & Outreach Assets Existing tech stack and digital tools (SOGI Universe, open-access resources) combined with engagement at major HIV conferences indicate readiness for funded digital health education platforms, data collection systems, and scalable e-learning or awareness campaigns.

Governance & Growth Strong focus on vulnerable populations and public health impact positions the foundation for social impact investments, capacity-building programs, and expansion into new African markets through grant-funded programs and technology-enabled health interventions.